Hyperbaric oxygen therapy in the treatment of ischemic lower-extremity ulcers in patients with diabetes: Results of the DAMO2CLES multicenter randomized clinical trial

Diabetes Care

Volumn 41, Issue 1, 2018, Pages 112-119

  Santema, Katrien T B ^a   Stoekenbroek, Robert M ^a   Koelemay, Mark J W ^a   Reekers, Jim A ^a   Van Dortmont, Laura M C ^b   Oomen, Arno ^c   Smeets, Luuk ^d   Wever, Jan J ^e   Legemate, Dink A ^a   Ubbink, Dirk T ^a  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b Vlietland Hospital   (Netherlands)

^c ST ANNA HOSPITAL   (Netherlands)

^d RIJNSTATE HOSPITAL   (Netherlands)

^e HAGA HOSPITAL   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

OXYGEN;

AGED; AMPUTATION FREE SURVIVAL; ARTICLE; CLINICAL OUTCOME; CLINICAL PROTOCOL; CONTROLLED STUDY; DIABETES MELLITUS; FEMALE; HUMAN; HYPERBARIC OXYGEN THERAPY; LEG AMPUTATION; LEG ISCHEMIA; LEG ULCER; LIMB SALVAGE; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTICENTER STUDY; PARALLEL DESIGN; RANDOMIZED CONTROLLED TRIAL; SURVIVAL; WOUND HEALING; AMPUTATION; BODY MASS; CLINICAL TRIAL; FOLLOW UP; ISCHEMIA; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; SAMPLE SIZE; TREATMENT OUTCOME; ULCER; VERY ELDERLY;

AGED; AGED, 80 AND OVER; AMPUTATION; BODY MASS INDEX; DIABETES MELLITUS, TYPE 2; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERBARIC OXYGENATION; ISCHEMIA; LIMB SALVAGE; MALE; MIDDLE AGED; SAMPLE SIZE; TREATMENT OUTCOME; ULCER; WOUND HEALING;

EID: 85038950180     PISSN: 01495992     EISSN: 19355548     Source Type: Journal    
DOI: 10.2337/dc17-0654     Document Type: Article

References (24)

1. Hunt DL. Diabetes: foot ulcers, and amputations. BMJ Clin Evid 2011; 2011: pii: 0602
2. International Diabetes Federation. IDF Diabetes Atlas, 7th ed. Brussels, Belgium, International Diabetes Federation, 2013
3. Boulton AJ. The diabetic foot: grand overview, epidemiology, and pathogenesis. Diabetes Metab Res Rev 2008; 24(Suppl. 1): S3-S6
4. Boulton AJ. The pathway to foot ulceration in diabetes.Med Clin North Am 2013; 97: 775-790
5. Schaper NC, Van Netten JJ, Apelqvist J, Lipsky BA, Bakker K; InternationalWorking Group on the Diabetic Foot. Prevention, and management of foot problems in diabetes: a summary guidance for daily practice 2015, based on the IWGDF guidance documents. Diabetes Metab Res Rev 2016; 32(Suppl. 1): 7-15
6. Boulton AJ, Vileikyte L, Ragnarson-Tennvall G, Apelqvist J. The global burden of diabetic foot disease. Lancet 2005; 366: 1719-1724
7. Nabuurs-Franssen MH, Huijberts MS, Nieuwenhuijzen Kruseman AC, Willems J, Schaper NC. Health-related quality of life of diabetic foot ulcer patients, and their caregivers. Diabetologia 2005; 48: 1906-1910
8. Moulik PK, Mtonga R, Gill GV. Amputation, and mortality in new-onset diabetic foot ulcers stratified by etiology. Diabetes Care 2003; 26: 491-494
9. Valensi P, Girod I, Baron F, Moreau-Defarges T, Guillon P. Quality of life, and clinical correlates in patients with diabetic foot ulcers. DiabetesMetab 2005; 31: 263-271
10. Hinchliffe RJ, Andros G, Apelqvist J, et al. A systematic review of the effectiveness of revascularization of the ulcerated foot in patients with diabetes, and peripheral arterial disease [published correction appears in Diabetes Metab Res Rev 2012; 28: 376]. DiabetesMetab Res Rev 2012; 28(Suppl. 1): 179-217
11. Unfirer S, Kibel A, Drenjancevic-Peric I. The effect of hyperbaric oxygen therapy on blood vessel function in diabetesmellitus.Med Hypotheses 2008; 71: 776-780
12. Flegg JA, Byrne HM, McElwainDL.Mathematical model of hyperbaric oxygen therapy applied to chronic diabetic wounds. Bull Math Biol 2010; 72: 1867-1891
13. Thackham JA, McElwain DL, Long RJ. The use of hyperbaric oxygen therapy to treat chronic wounds: a review. Wound Repair Regen 2008; 16: 321-330
14. Stoekenbroek RM, Santema TB, Legemate DA, Ubbink DT, Van Den Brink A, Koelemay MJ. Hyperbaric oxygen for the treatment of diabetic foot ulcers: a systematic review. Eur J Vasc Endovasc Surg 2014; 47: 647-655
15. Elraiyah T, Tsapas A, Prutsky G, et al. A systematic review, and meta-analysis of adjunctive therapies in diabetic foot ulcers. J Vasc Surg 2016; 63: 46S.e1-2-58S.e1-2
16. Kranke P, Bennett MH, Martyn-St James M, Schnabel A, Debus SE, Weibel S. Hyperbaric oxygen therapy for chronic wounds. Cochrane Database Syst Rev 2015; 6: CD004123
17. Schulz KF, Altman DG, Moher D; CONSORT Group. CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. BMJ 2010; 340: c332
18. Stoekenbroek RM, Santema TB, Koelemay MJ, et al. Is additional hyperbaric oxygen therapy cost-effective for treating ischemic diabetic ulcers? Study protocol for the Dutch DAMOCLES multicenter randomized clinical trial? J Diabetes 2015; 7: 125-132
19. World Medical A; World Medical Association. World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects. JAMA 2013; 310: 2191-2194
20. Abidia A, Laden G, Kuhan G, et al. The role of hyperbaric oxygen therapy in ischaemic diabetic lower extremity ulcers: a double-blind randomisedcontrolled trial. Eur J Vasc Endovasc Surg 2003; 25: 513-518
21. Faglia E, Favales F, Aldeghi A, et al. Adjunctive systemic hyperbaric oxygen therapy in treatment of severe prevalently ischemic diabetic foot ulcer. A randomized study. Diabetes Care 1996; 19: 1338-1343
22. Löndahl M, Katzman P, Nilsson A, Hammarlund C. Hyperbaric oxygen therapy facilitates healing of chronic foot ulcers in patients with diabetes. Diabetes Care 2010; 33: 998-1003
23. Fedorko L, Bowen JM, Jones W, et al. Hyperbaric oxygen therapy does not reduce indications for amputation in patients with diabetes with nonhealing ulcers of the lower limb: a prospective, double-blind, randomized controlled clinical trial. Diabetes Care 2016; 39: 392-399
24. Duzgun AP, Satir HZ, Ozozan O, Saylam B, Kulah B, Coskun F. Effect of hyperbaric oxygen therapy on healing of diabetic foot ulcers. J Foot Ankle Surg 2008; 47: 515-519